Australia's most trusted
source of pharma news
Thursday, 05 June 2025
Posted 2 June 2025 PM
A new strength of Novo Nordisk’s blockbuster diabetes treatment and new pack sizes of two Boehringer Ingelheim inhalers have joined the PBS this month.
This includes Novo Nordisk’s Ozempic 2mg in 3mL pre-filled injector pen for patients with type 2 diabetes. This new strength is expected to replace the existing PBS listing of Ozempic 2mg in 1.5mL pre-filled injector pen.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.